The feasibility of Gazefinder under 12 months of age infants.
Fukushima S, Takahashi T, Tsukamoto K, Matsumura M, Takigawa R, Sakai Y, Maniwa S, Murphy L, Taketani T.
Fukushima S, et al. Among authors: takigawa r.
Sci Rep. 2021 May 11;11(1):10009. doi: 10.1038/s41598-021-89585-7.
Sci Rep. 2021.
PMID: 33976346
Free PMC article.
Clinical Trial.